Evidence map›Paper›PMID 27574423›Full record

ArticleInternational journal of nanomedicine2016

Dual delivery of active antibactericidal agents and bone morphogenetic protein at sustainable high concentrations using biodegradable sheath-core-structured drug-eluting nanofibers.

Yung-Hen Hsu, Chang-Tun Lin, Yi-Hsun Yu, Ying-Chao Chou, Shih-Jung Liu, Err-Cheng Chan

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Coaxial electrospun fibers for control release of vancomycin and diclofenac in osteomyelitis management.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. JanusRSC advances · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yung-Hen HsuDepartment of Orthopedic Surgery, Chang Gung Memorial Hospital; Department of Mechanical Engineering.
Chang-Tun LinDepartment of Mechanical Engineering.
Yi-Hsun YuDepartment of Orthopedic Surgery, Chang Gung Memorial Hospital; Department of Mechanical Engineering.
Ying-Chao ChouDepartment of Orthopedic Surgery, Chang Gung Memorial Hospital; Department of Mechanical Engineering.
Shih-Jung LiuDepartment of Orthopedic Surgery, Chang Gung Memorial Hospital; Department of Mechanical Engineering.
Err-Cheng ChanDepartment of Medical Biotechnology and Laboratory Science, School of Medical Technology, Chang Gung University, Tao-Yuan, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we developed biodegradable sheath-core-structured drug-eluting nanofibers for sustainable delivery of antibiotics (vancomycin and ceftazidime) and recombinant human bone morphogenetic protein (rhBMP-2) via electrospinning. To prepare the biodegradable sheath-core nanofibers, we first prepared solutions of poly(d,l)-lactide-co-glycolide, vancomycin, and ceftazidime in 1,1,1,3,3,3-hexafluoro-2-propanol and rhBMP-2 in phosphate-buffered solution. The poly(d,l)-lactide-co-glycolide/antibiotics and rhBMP-2 solutions were then fed into two different capillary tubes controlled by two independent pumps for coaxial electrospinning. The electrospun nanofiber morphology was observed under a scanning electron microscope. We further characterized the in vitro antibiotic release from the nanofibers via high-performance liquid chromatography and that of rhBMP-2 via enzyme-linked immunosorbent assay and alkaline phosphatase activity. We showed that the biodegradable coaxially electrospun nanofibers could release high vancomycin/ceftazidime concentrations (well above the minimum inhibition concentration [MIC]90) and rhBMP-2 for >4 weeks. These experimental results demonstrate that novel biodegradable nanofibers can be constructed with various pharmaceuticals and proteins for long-term drug deliveries.

Indexed as

Drug Delivery SystemsAnimalsAnti-Bacterial AgentsBiocompatible MaterialsBone Morphogenetic Protein 2CeftazidimeDrug LiberationHumansLactic AcidMicrobial Sensitivity TestsNanofibersPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerRats, Sprague-DawleySpectroscopy, Fourier Transform InfraredTensile StrengthAnti-Bacterial AgentsBiocompatible MaterialsBone Morphogenetic Protein 2CeftazidimeLactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerVancomycinWaterbiodegradable sheath-core nanofibersceftazidimecoaxial electrospinningrelease characteristicsrhBMP-2vancomycin

Identifiers

PMID27574423
PMCPMC4993267

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.